Cargando…
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
Background. The relative rarity and diversity of fibrotic interstitial lung disease (ILD) have made it challenging to study these diseases in single-centre cohorts. Here we describe formation of a multicentre Canadian registry that is needed to describe the outcomes of fibrotic ILD and to enable det...
Autores principales: | Ryerson, Christopher J., Tan, Benjamin, Fell, Charlene D., Manganas, Hélène, Shapera, Shane, Mittoo, Shikha, Sadatsafavi, Mohsen, To, Teresa, Gershon, Andrea, Fisher, Jolene H., Johannson, Kerri A., Hambly, Nathan, Khalil, Nasreen, Marras, Theodore K., Morisset, Julie, Wilcox, Pearce G., Halayko, Andrew J., Khan, Mohammad Adil, Kolb, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904524/ https://www.ncbi.nlm.nih.gov/pubmed/27445528 http://dx.doi.org/10.1155/2016/3562923 |
Ejemplares similares
-
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
por: Fisher, J. H., et al.
Publicado: (2019) -
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
por: Lee, Cathryn T., et al.
Publicado: (2022) -
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort
por: Marcoux, Veronica, et al.
Publicado: (2023) -
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020) -
Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease
por: Chen, Tao, et al.
Publicado: (2021)